Integrated DNA Technologies (IDT), a global leader in genomics solutions, announced  the expansion of its gene synthesis services with the launch of a pioneering custom vector onboarding tool. This novel, easy-to-use solution enables researchers to bypass traditional in-house cloning processes, facilitating swift progression into functional studies with 100% sequence-verified clonal DNA.

The custom vector onboarding tool is designed for seamless integration into IDT's online platform, allowing researchers to submit their vector sequences directly through the IDT website. This eliminates the need for intermediary communication with sales representatives, streamlining the submission process and significantly reducing turnaround times.

Key benefits of using IDT's custom vector onboarding service include:

• Time Efficiency: Researchers can save valuable time as IDT takes over the cloning process, enabling them to order fully cloned genes in their custom vectors at any time.
• Cost-Effectiveness: The service requires a one-time onboarding fee of $500 for a custom vector, with no additional charges for subsequent orders of inserts in the onboarded vector, and no minimum order quantity.
• Guaranteed Confidentiality: IDT prioritizes the security and confidentiality of its online ordering process, ensuring that all submitted sequences are protected, thus safeguarding intellectual property.

Sandy Ottensmann, VP/GM of Gene Writing and Editing at IDT, emphasized the importance of efficiency and speed in contemporary research. "Gene synthesis is at the heart of innovation in synthetic biology, driving the cycle of design, build, test, and learn. Our new custom vector onboarding tool is a testament to our commitment to supporting researchers by providing them with the tools they need for rapid and cost-efficient development at scale."

This addition to IDT's synthetic biology portfolio, which includes an array of gene and gene fragment offerings, underscores the company's role as a major provider of synthetic DNA solutions. IDT can produce gene fragments ranging from 125 bp to 3 kb and custom genes from 25 bp up to 5 kb in length, with genes exceeding 5 kb available through custom quotes.

 Looking ahead to the second half of 2024, IDT plans to leverage its expanded U.S.-based synthetic biology manufacturing facility footprint to further enhance its gene synthesis portfolio with differentiated offerings.